ALDH3A2 and Sjögren-Larsson syndrome: Studies demonstrating the efficacy of correcting an enzyme deficiency in Sjogren-Larsson syndrome by delivering the fatty aldehyde dehydrogenase (FALDH) gene using AAV vectors have become an important proof of concept [10].